Synthesis and anticancer activity of some pyrimidine derivatives with aryl urea moieties as apoptosis-inducing agents

被引:40
作者
Kilic-Kurt, Zuhal [1 ]
Ozmen, Nuri [2 ]
Bakar-Ates, Filiz [2 ]
机构
[1] Ankara Univ, Fac Pharm, Dept Pharmaceut Chem, Ankara, Turkey
[2] Ankara Univ, Fac Pharm, Dept Biochem, Ankara, Turkey
关键词
Pyrimidines; Urea; Anticancer; Apoptosis mechanism; Synthesis; BCR-ABL; KAPPA-B; DESIGN; INHIBITOR; POTENT; DISCOVERY; TARGETS; GROWTH; AURORA;
D O I
10.1016/j.bioorg.2020.104028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A new series of pyrimidine derivatives containing aryl urea moieties was designed and synthesized. The an-ticancer activities of all compounds were evaluated in vitro against colon and prostat cancer cell lines by MTT assay. Among these compounds, 4b exhibited the highest cytotoxic activity against SW480 cancer cell line with IC50 value of 11.08 mu M. Mechanistic studies showed that compound 4b arrested cell cycle at G2/M phase and induced apoptosis through upregulating Bax, Ikb-alpha and cleaved PARP and downregulating Bcl-2 expression levels. Moreover, compound 4b induced loss of mitochondrial membrane potential in SW480 cells. These results suggest that pyrimidine with urea moieties could be a template for designing new anticancer agents.
引用
收藏
页数:10
相关论文
共 35 条
[1]   Synthesis and in vitro biological evaluation of new pyrimidines as glucagon-like peptide-1 receptor agonists [J].
AlNeyadi, Shaikha S. ;
Adem, Abdu ;
Amer, Naheed ;
Salem, Alaa A. ;
Abdou, Ibrahim M. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (22) :5071-5075
[2]   CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins [J].
Carroll, M ;
OhnoJones, S ;
Tamura, S ;
Buchdunger, E ;
Zimmermann, J ;
Lydon, NB ;
Gilliland, DG ;
Druker, BJ .
BLOOD, 1997, 90 (12) :4947-4952
[3]   Design, synthesis and anticancer studies of novel aminobenzazolyl pyrimidines as tyrosine kinase inhibitors [J].
Chikhale, Rupesh ;
Thorat, Sonali ;
Choudhary, Rajan Kumar ;
Gadewal, Nikhil ;
Khedekar, Pramod .
BIOORGANIC CHEMISTRY, 2018, 77 :84-100
[4]   Synthesis of 6-aryl-2,4-diamino-pyrimidines and triazines using palladium catalysed Suzuki cross-coupling reactions [J].
Cooke, G ;
de Cremiers, HA ;
Rotello, VM ;
Tarbit, B ;
Vanderstraeten, PE .
TETRAHEDRON, 2001, 57 (14) :2787-2789
[5]   Design, synthesis and antiproliferative activity studies of novel 1,2,3-triazole-dithiocarbamate-urea hybrids [J].
Duan, Ying-Chao ;
Zheng, Yi-Chao ;
Li, Xiao-Chen ;
Wang, Meng-Meng ;
Ye, Xian-Wei ;
Guan, Yuan-Yuan ;
Liu, Gai-Zhi ;
Zheng, Jia-Xin ;
Liu, Hong-Min .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 64 :99-110
[6]   Design and synthesis of new anticancer pyrimidines with multiple-kinase inhibitory effect [J].
El-Deeb, Ibrahim Mustafa ;
Lee, So Ha .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (11) :3860-3874
[7]   New triarylpyrazoles as broad-spectrum anticancer agents: Design, synthesis, and biological evaluation [J].
El-Gamal, Mohammed I. ;
Park, Yi Seul ;
Chi, Dae Yoon ;
Yoo, Kyung Ho ;
Oh, Chang-Hyun .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 65 :315-322
[8]   Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL [J].
Finucane, DM ;
Bossy-Wetzel, E ;
Waterhouse, NJ ;
Cotter, TG ;
Green, DR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (04) :2225-2233
[9]   Synthesis and evaluation of novel ligands for the histamine H4 receptor based on a pyrrolo[2,3-d]pyrimidine scaffold [J].
Gao, Ling-Jie ;
Schwed, J. Stephan ;
Weizel, Lilia ;
De Jonghe, Steven ;
Stark, Holger ;
Herdewijn, Piet .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (01) :132-137
[10]   Rational design and characterization of a Rac GTPase-specific small molecule inhibitor [J].
Gao, Y ;
Dickerson, JB ;
Guo, F ;
Zheng, J ;
Zheng, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (20) :7618-7623